Late this afternoon, China Yunhong Holdings (ZGYHU) made a surprise appearance by filing an amended S-1, indicating their IPO is back on. However, the terms have been changed so this is the “new”, revamped China Yunhong.
Just to recap for a moment, China Yunhong originally filed it’s first S-1 back at the end of June, with terms that were atypical of the smaller, Asia-focused deals. That is, they filed with one full warrant, 18 months duration, and a warrant call trigger of $18.00. However, it seems China Yunhong has decided to now revert back to the standard smaller deal structure and file with 1 warrant for 1/2 share, 12 months duration (plus three 3-month extensions for $0.10 to trust for each extension), and a warrant call trigger of $16.50. Plus, they’ve also added a right to the unit (1/10). Lastly, the new amended S-1 has added five new team members, whereas in the original filing, Mr. Yubao Li was the only team member listed.
As for the new team, Mr. Andrey Novikov, who is currently on the board of Qpagos (OTC: QPAG), a US-based provider of physical and virtual payment services in the Mexican Market, as well as previously served as an advisor of QIWI PLC (NASDAQ: QIWI), a payment services provider in Russia, will now be the CEO. Mr. Yubao Li, who was previously Chairman and CEO, will be just Chairman.
So, again, while the team is now fully fleshed out, the terms have reverted to the standard smaller deal-size playbook. Is that a good thing? Well, as was discussed previously, deals that have a right included in the unit have historically not done well. In the past three years, only one deal with rights – Atlantic Acquisition Corp. (HFFG) – has managed to trade above the $10.00 level post-combination closing. And Atlantic had an unusual structure in that it ONLY had a share and a right, no warrants were included in the unit. (note: technically, you can also include Forum Merger I as a successful SPAC with rights since it’s combination (ConvergeOne) was bought post-merger for $12.50 by CVC Fund VII. However, Forum originally did a PIPE at $8.00 per share as part of its transaction).
Nonetheless, if the feedback the bankers received was that investors wanted an amended structure with rights, then feeding the beast by giving them those terms is one solution. However, over-funding the trust at 101%, or $10.10 in trust at IPO, could have been another solution (or at least one I wish they had considered). Given that we are now in a falling interest rate environment and that earned interest is looking a little lean, which is more palatable? — one full warrant and $10.10 in trust? Or, one warrant for 1/2 share and a right at $10.00 in trust? Plus, if a combination is not a clear-cut winner at the shareholder vote, then rights usually end up being share price killers post-close (a large number of redemptions = low float, followed by an influx of rights shares looking to sell immediately).
This is all academic, but it is interesting that teams are still opting to include a right in the unit. However, the revised terms below are what China Yunhong is currently working with. If any additional changes are made, an update will be provided.
Revised terms:
December 2024 corporate actions continues the trend of SPAC teams seeking additional extensions beyond their third round, as they work to close their combinations with the remaining funds after redemptions. Despite this activity, both announcements and corporate actions associated with completion votes were notably few this month. Extension Votes In December, there were 26 scheduled...
At the SPAC of Dawn 2025 dawns with a reminder to SPAC teams that, as the Rolling Stones song goes, “You can’t always get what you want.” That was the message sent by Aimei Health I (NASDAQ:AFJK) shareholders as they rejected a proposal to reduce the SPAC’s monthly contribution to trust for the duration of...
An In-Depth Look at SPAC Activity Throughout the Full-Year of 2024 Below is a summary of the Full-Year 2024 SPAC market. If you’d like a pdf copy, you access the link HERE. SPACs have emerged from 2024 with a cautious optimism that feels both hard-earned and fragile. After weathering the turbulence of the past few...
The next quarter century is starting off with a set of de-SPAC shareholders newly able to realize better gains as their lock-ups expire in January than most months through 2024. Eight de-SPACs and six sponsors are to see their shares unlocked next month, and while none of these companies finished trading on December 30 in...
Maywood Acquisition Corp. (NASDAQ:MAYAU) filed to list a $75 million SPAC on the penultimate day of 2024 with a CEO making his second rodeo and a focus on serving the demand for listing opportunities and exits in Asia-Pacific. This new SPAC is not overfunding its trust and will have rights to a 1/5 share in...